(in millions $) | 1 May 2025 | 31 Jan 2025 | 30 Oct 2024 | 30 Jul 2024 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | ||||
Inventory | ||||
Total current assets | ||||
Long term investments | ||||
Property, plant & equipment | ||||
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | ||||
Current liabilities | ||||
Accounts payable | ||||
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | ||||
Long term debt | ||||
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | ||||
Shareholders' equity | ||||
Retained earnings | ||||
Other shareholder equity | ||||
Total shareholder equity |
(in millions $) | 31 Jan 2025 | 31 Jan 2024 | 31 Jan 2023 | 30 Mar 2022 |
---|---|---|---|---|
Current assets | ||||
Cash | $2669 | |||
Short term investments | $934.1 | |||
Net receivables | $76.4 | $59.7 | $43.5 | |
Inventory | $6.2 | $6 | $4.3 | |
Total current assets | $5827.1 | $5911.4 | $5475.1 | |
Long term investments | ||||
Property, plant & equipment | $11013.5 | $10118 | $9228.8 | |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $17175.6 | $16405.9 | $15149.8 | |
Current liabilities | ||||
Accounts payable | $792.2 | $1065.5 | $1029 | |
Deferred revenue | ||||
Short long term debt | $998.5 | |||
Total current liabilities | $6400.6 | $7421.6 | $5398.7 | |
Long term debt | $2657.4 | $3016.3 | $3714.6 | |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $9561.4 | $10762.9 | $9604.5 | |
Shareholders' equity | ||||
Retained earnings | $6203 | $4256.2 | $2880.9 | |
Other shareholder equity | $266 | $31 | $1329.4 | |
Total shareholder equity | $5545.3 |
(in millions $) | 30 Jul 2025 | 1 May 2025 | 31 Jan 2025 | 30 Oct 2024 |
---|---|---|---|---|
Revenue | ||||
Total revenue | ||||
Cost of revenue | ||||
Gross Profit | ||||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | ||||
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | ||||
Interest expense | ||||
Net income | ||||
Net income | ||||
Income (for common shares) |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Mar 2022 | 30 Mar 2021 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $4800.9 | $1635.8 | ||
Cost of revenue | $4009.8 | $1702.7 | ||
Gross Profit | $791.1 | -$66.9 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $411.3 | $201.5 | ||
Total operating expenses | $5140.5 | $2475.2 | ||
Operating income | -$339.6 | -$839.4 | ||
Income from continuing operations | ||||
EBIT | -$339.6 | -$839.4 | ||
Income tax expense | -$189 | -$93.6 | ||
Interest expense | -$91.4 | -$53.8 | ||
Net income | ||||
Net income | -$240.8 | -$1015.1 | ||
Income (for common shares) | -$240.8 | -$1015.1 |
(in millions $) | 1 May 2024 | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$1560.4 | -$1258.2 | -$893.7 | -$1873 |
Financing activities | ||||
Dividends paid | -$199.5 | |||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$1326.3 | -$1100.6 | -$1089.6 | -$23.1 |
Effect of exchange rate | $4.9 | -$7.6 | $4.1 | |
Change in cash and equivalents | $276.1 | -$1080.7 | -$338.8 | -$644.5 |
(in millions $) | 1 May 2024 | 1 May 2023 | 30 Mar 2022 | 30 Mar 2021 |
---|---|---|---|---|
Net income | -$240.8 | -$1015.1 | ||
Operating activities | ||||
Depreciation | $719.4 | $571 | ||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | $1940.5 | -$2448 | ||
Investing activities | ||||
Capital expenditures | -$1181.6 | -$294.7 | ||
Investments | -$468.6 | $741.7 | ||
Total cash flows from investing | -$1560.4 | -$1901.2 | -$1414.4 | $937.1 |
Financing activities | ||||
Dividends paid | -$199.5 | |||
Sale and purchase of stock | ||||
Net borrowings | -$583.3 | $1201.5 | ||
Total cash flows from financing | -$1326.3 | -$1054 | -$536.5 | $1622.5 |
Effect of exchange rate | $4.9 | -$5.5 | $28.7 | -$27.3 |
Change in cash and equivalents | $276.1 | $930.3 | $18.3 | $84.3 |
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | N/A |
Quick ratio | N/A |